From Health Affairs <[email protected]>
Subject Exclusive Event: FDA Breakthrough Therapy Designation Insights
Date July 11, 2024 2:05 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

health-affairs-event-journal-club-generic-2023_eNewsletter ([link removed] )

John,

Join this event featuring a closer look at a new Health Affairs research article, “FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Times ([link removed] ) ,” published in the July 2024 issue of the journal.

This event is exclusive to our Health Affairs Insiders.

Become an Insider Today
([link removed] )

Join us Tuesday, July 23, for a Health Affairs Journal Club event discussing the US Food and Drug Administration’s breakthrough therapy designation (BTD) program, one of several programs designed to expedite the development and approval of critical new drugs.

In “FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Times ([link removed] ) ,” Kathleen L. Miller and colleagues analyze drug approval data and estimate that “the BTD program lowers late-stage clinical development time by 30 percent.”

The authors assert that the findings will “inform future regulatory and innovation policies aimed at driving efficiency in medical product development to ensure timely patient access to the most clinically meaningful therapies.”

On July 23, Miller, the deputy director in the Division of Science and Public Health Policy in the HHS Office of Science and Data Policy, will discuss the paper’s findings, data and methods with Health Affairs Deputy Editor Jessica Bylander.

Date: Tuesday, July 23, 2024

Time: 3:00 p.m. – 4:00 p.m. Eastern

Place: Online details will be shared with registrants 24 hours in advance of the event

Register
([link removed] )

If you have accessibility or support requirements in order to participate fully in this event, please contact [email protected] (mailto:[email protected]) to ensure that we can arrange reasonable accommodations.

Also, sign up for our free daily and weekly newsletters to never miss an event, an article, podcast, or health policy brief.

health-affairs-newsletter-sign-up-2023_email-banner-02 ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1220 19th St. NW, Suite 800, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis